Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. De plus, nous expédions TNFRSF8 Kits (43) et TNFRSF8 Protéines (31) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 805 products:
Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN2689176
Amakawa, Hakem, Kundig, Matsuyama, Simard, Timms, Wakeham, Mittruecker, Griesser, Takimoto, Schmits, Shahinian, Ohashi, Penninger, Mak: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. dans Cell 1996
Show all 12 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour IHC (f), FACS - ABIN2749180
Aalberse, Kapitein, de Roock, Klein, de Jager, van der Zee, Hoekstra, van Wijk, Prakken: Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60). dans PLoS ONE 2011
Show all 5 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour IHC (f), FACS - ABIN2749181
Falini, Pileri, Pizzolo, Dürkop, Flenghi, Stirpe, Martelli, Stein: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. dans Blood 1995
Show all 5 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN610027
Dayanir, Meyer, Lashkari, Rahimi: Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. dans The Journal of biological chemistry 2001
Show all 2 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour FACS, ELISA - ABIN969019
Kamali, Abbasi, Farokhi, Abbasi, Fallah, Seifee, Ghadimi, Rezaie: Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. dans Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2010
Human Monoclonal TNFRSF8 Primary Antibody pour IHC (fro), IF - ABIN2479874
Lacroix, Collot-Teixeira, Mardivirin, Jaccard, Petit, Piguet, Sturtz, Preux, Bordessoule, Ranger-Rogez: Involvement of human herpesvirus-6 variant B in classic Hodgkin's lymphoma via DR7 oncoprotein. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Human Monoclonal TNFRSF8 Primary Antibody pour ELISA - ABIN2479876
Brodsky, Guidotti: Hydrolytic properties of the (Na+ + K+)-ATPase isozymes for beta-(2-furyl)acryloyl phosphate, a pseudosubstrate for the sodium pump. dans Biochemical and biophysical research communications 1990
Show all 2 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour FACS - ABIN2689175
Guesdon, Ternynck, Avrameas: The use of avidin-biotin interaction in immunoenzymatic techniques. dans The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1979
Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN192353
Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. dans Clinical and vaccine immunology : CVI 2009
Show all 7 Pubmed References
Human Monoclonal TNFRSF8 Primary Antibody pour FACS, IHC (p) - ABIN192355
Wright, Rumble, Duckett: CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. dans The Journal of biological chemistry 2007
Show all 7 Pubmed References
CD30+ diffuse large B-cell lymphoma has characteristic clinicopathological features mutually exclusive with MYC (Montrer MYC Anticorps) gene rearrangement and negatively associated with BCL2 (Montrer BCL2 Anticorps) protein expression.
Data suggest that CD4 (Montrer CD4 Anticorps)+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30; cells expressing this marker considerably contribute to total pool of transcriptionally active CD4 (Montrer CD4 Anticorps)+ lymphocytes in individuals on suppressive anti-retroviral drug therapy; CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in blood and in gut (Montrer GUSB Anticorps)-associated lymphoid tissue.
The stable elevation in classical Hodgkin lymphoma risk with elevated levels of sCD30 and IL6 (Montrer IL6 Anticorps) across 4 or more years prior to diagnosis may also reflect a B-cell-stimulatory environment that promotes the genesis of these cancers.
extranodal NK/T-cell lymphoma, nasal type(ENKTL) is the most common type of mature T-cell and NK-cell lymphoma diagnosed at our institution. CD30 is frequently expressed in ENKTL and represents a therapeutic target; however, it may not be a prognostic marker.
This study suggests that in patients with CD30+ lymphoproliferative disorders, an aggressive clinical course cannot be defined by the presence of TP63 rearrangements, as was recently shown in systemic ALK negative anaplastic large cell lymphoma.
Data suggest that Brentuximab Vedotin (SGN-35) damaged CD30 ligand (CD30L (Montrer TNFSF8 Anticorps))-immune cells through CD30 extracellular vesicles (EVs).
median FoxP3 (Montrer FOXP3 Anticorps)+ Treg count was higher in CD30+ than in CD30- posttransplant lymphoproliferative disorders, 3.0 vs 0
Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (Montrer EFS Anticorps), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.
Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (Montrer MYC Anticorps) oncogene (Montrer RAB1A Anticorps)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.
Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.
This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (Montrer CD4 Anticorps) T cells at the induction phase of experimental autoimmune encephalomyelitis.
Data indicate that CD30L (Montrer TNFSF8 Anticorps)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).
role in the maintenance and activation of IL-17A (Montrer IL17A Anticorps)-producing gammadelta T cells
These results suggest that CD30 signaling plays an important role in the activation of IL-17A (Montrer IL17A Anticorps)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (Montrer SLC11A1 Anticorps) infection.
Interference of the CD30-CD30L (Montrer TNFSF8 Anticorps) pathway reduces atherosclerosis development.
CD30L (Montrer TNFSF8 Anticorps)/CD30 pathway acts as an accelerator of enteritis in a murine disease model
role of CD30L (Montrer TNFSF8 Anticorps)/CD30 interactions in allergic rhinitis; results suggest that CD30L (Montrer TNFSF8 Anticorps) plays an important role in allergic rhinitis
Abrogation of CD30 and OX40 (Montrer TNFRSF4 Anticorps) signals prevents autoimmune disease in FoxP3 (Montrer FOXP3 Anticorps)-deficient mice.
Studies demonstrate that CD30L (Montrer TNFSF8 Anticorps)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.
CD30 can signal in a completely TCR-independent fashion to induce IL-13 (Montrer IL13 Anticorps) production by effector T cells.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
, Ki-1 antigen
, cytokine receptor CD30
, lymphocyte activation antigen CD30
, tumor necrosis factor receptor superfamily member 8
, Tumor necrosis factor superfamily member 8
, tumor necrosis factor superfamily, member CD30
, tumor necrosis factor receptor superfamily, member 8
, tumor necrosis factor receptor superfamily member 8-like